InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by HOUGEN ELIZABETH L, Chief Financial Officer. Officer active across 1 companies, notably Ionis Pharmaceuticals INC. Aggregated, 7 disclosures have been published. The latest transaction was disclosed on 16 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
US$3m60,299 shares@ US$53.24830.025% mcap99.9% of flow
Common Stock
SEC:0000874015-26-000146·
€3m60,299 shares@ €53.24830.025% mcap49.9% of flow
Common Stock
SEC:0000874015-26-000146:0·
€9,744384 shares@ €25.3760.0001% mcap0.2% of flow
Common Stock
SEC:0000874015-22-000088:0·
022,050 shares0
Common Stock
SEC:0000874015-22-000054·
022,050 shares0
Common Stock
SEC:0000874015-22-000054:0·
€4,750166 shares@ €28.61570.0000% mcap0.1% of flow
Common Stock
SEC:0000874015-21-000154·
€4,750166 shares@ €28.61570.0000% mcap0.1% of flow
Common Stock
SEC:0000874015-21-000154:0·
7 of 7 declarations
About HOUGEN ELIZABETH L
Elizabeth L. Hougen is Chief Financial Officer at Ionis Pharmaceuticals Inc. She is responsible for the financial management of the company, including budgeting and financial analysis. With a strong background in corporate finance, Elizabeth plays a key role in financial strategy and decision-making. Her expertise is essential in ensuring the financial health of Ionis Pharmaceuticals Inc.
